Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded
- Contract number
- SPE2DB25FR2ZT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,396
Award facts
- Contract value 100% obligated
- $18,396.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,396.26 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL formulations. This firm fixed-price, non-set-aside delivery order was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive portfolio of medications and medical supplies to military and veteran healthcare systems through competitive federal contracting. The company's extensive federal contract history demonstrates consistent capability in delivering brand-name and generic pharmaceuticals, including diabetes medications, specialty treatments, and medical devices across multiple therapeutic domains. This specific delivery order supports the Defense Health Agency and other government healthcare systems' pharmaceutical supply requirements within the broader Pharmaceutical Prime Vendor Global Program framework.
Quick answers
Who was awarded contract SPE2DB25FR2ZT?
SPE2DB25FR2ZT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 21, 2025.
How much is contract SPE2DB25FR2ZT worth?
The government has obligated $18,396 on SPE2DB25FR2ZT.
Is contract SPE2DB25FR2ZT an order under another contract?
Yes. SPE2DB25FR2ZT is a delivery order under SPE2DB22D2218, an indefinite delivery contract.
Was contract SPE2DB25FR2ZT competed?
The extent of competition for SPE2DB25FR2ZT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award